1. Telomir-1 reverses calcium dysregulation and oxidative stress in human cells. 2. Findings support Telomir's role in age-reversal science and cellular protection.
The study reinforces Telomir's innovative therapeutic approach, likely increasing investor interest. Effective age-reversal treatments can significantly drive revenue similar to companies like Elysium Health after breakthrough studies.
The study's focus on cellular integrity and oxidative stress is central to Telomir's mission, making it crucial for stakeholders evaluating TELO.
Positive preclinical findings pave the way for future clinical trials and market potential, akin to how successful aging therapies have developed over time.